project id: TCGA-CESC; case submitter id: TCGA-EK-A2RO; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.0; age at index: 59; days to birth: -21844; ethnicity: hispanic or latino; gender: female; race: american indian or alaska native; vital status: Alive; year of birth: 1951; age at diagnosis: 21844; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 409; initial weight: 90.0; oct embedded: false; preservation method: Unknown; sample id: 31ea30da-ab0d-48af-bb1c-58f99ab033a9; sample submitter id: TCGA-EK-A2RO-01A; portion id: 14e7a79b-e95b-43b0-9c2e-eeb485440943; portion submitter id: TCGA-EK-A2RO-01A-11; slide id: 795824ef-504b-401d-bcf4-21d84544dec3; slide submitter id: TCGA-EK-A2RO-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 48.0; percent tumor cells: 50.0; percent tumor nuclei: 65.0; section location: TOP;